drugset / Trial / NCT06201715

Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis

NCT06201715

NaSingle-groupOpen-labelTreatment

Summary

The goal is to evaluate the efficacy and safety of tofacitinib in treating refractory prurigo nodularis.The main questions it aims to answer are 1. whether tofacitinib is effective in treating prurigo nodularis in the longpterm. 2. whether tofacitinib is safe in prurigo nodularis patients in the longpterm.

Timeline

Start
2024-05-01
Primary completion
2025-06-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofacitinib Small molecule 5 mg

Indications